Activation and regulation of chemokines in allergic airway inflammation - PubMed (original) (raw)
Review
doi: 10.1002/jlb.59.1.13.
Affiliations
- PMID: 8558061
- DOI: 10.1002/jlb.59.1.13
Free article
Review
Activation and regulation of chemokines in allergic airway inflammation
N W Lukacs et al. J Leukoc Biol. 1996 Jan.
Free article
Abstract
Allergic airway inflammation is characterized by peribronchial eosinophil accumulation with the submucosa surrounding the airway. The initial induction of immunoglobulin E (IgE)-mediated mast cell degranulation, up-regulation of adhesion molecules, and the production of inflammatory and chemotactic cytokines, leading to the infiltration of specific leukocyte subsets, is orchestrated in a sequential manner. The activation and degranulation of local mast cell populations is an immediate airway response mediated both by antigen-specific, surface bound IgE and by cytokine-induced activational pathways. Subsequently the infiltration and activation of effector leukocytes (neutrophils and eosinophils) mediated by the persistent activation of allergen-specific T cells leads to pathological manifestations within the lung and airway. The development of appropriate animal models to dissect the critical mechanisms involved in antigen-induced airway pathology is crucial for the development of efficacious therapies. We have utilized a model of allergic airway inflammation induced by intratracheal challenge with parasite (Schistosoma mansoni) egg antigen in presensitized mice. This model has proven useful in the assessment of eosinophil recruitment and has identified key cytokines involved in leukocyte elicitation. These cytokines include interleukin-4 and elicitation. These cytokines include interleukin-4 and tumor necrosis factor, which appear to act as early response mediators, as well as C-C chemokines, macrophage inflammatory protein-1a, and RANTES, which act directly on eosinophil recruitment. In addition, we have found that both C-X-C and C-C chemokines are expressed in pulmonary-derived mast cells, suggesting an important contribution to leukocyte responses in the allergic airway.
Similar articles
- Cytokines in allergic eosinophilic airway inflammation.
Lukacs NW. Lukacs NW. Biol Signals. 1996 Jul-Aug;5(4):209-14. doi: 10.1159/000109192. Biol Signals. 1996. PMID: 8891196 - Cytokine and Chemokine Interactions in Allergic Airway Inflammation.
Campbell EM, Lukacs NW. Campbell EM, et al. ILAR J. 1999 Sep;40(4):157-162. doi: 10.1093/ilar.40.4.157. ILAR J. 1999. PMID: 11406694 - Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation.
Lukacs NW, Strieter RM, Warmington K, Lincoln P, Chensue SW, Kunkel SL. Lukacs NW, et al. J Immunol. 1997 May 1;158(9):4398-404. J Immunol. 1997. PMID: 9127004 - The role of chemokines and chemokine receptors in eosinophil activation during inflammatory allergic reactions.
Oliveira SH, Lukacs NW. Oliveira SH, et al. Braz J Med Biol Res. 2003 Nov;36(11):1455-63. doi: 10.1590/s0100-879x2003001100002. Epub 2003 Oct 22. Braz J Med Biol Res. 2003. PMID: 14576899 Review. - The role of human mast cell-derived cytokines in eosinophil biology.
Shakoory B, Fitzgerald SM, Lee SA, Chi DS, Krishnaswamy G. Shakoory B, et al. J Interferon Cytokine Res. 2004 May;24(5):271-81. doi: 10.1089/107999004323065057. J Interferon Cytokine Res. 2004. PMID: 15153310 Review.
Cited by
- Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration.
Sodhi CP, Wohlford-Lenane C, Yamaguchi Y, Prindle T, Fulton WB, Wang S, McCray PB Jr, Chappell M, Hackam DJ, Jia H. Sodhi CP, et al. Am J Physiol Lung Cell Mol Physiol. 2018 Jan 1;314(1):L17-L31. doi: 10.1152/ajplung.00498.2016. Epub 2017 Sep 21. Am J Physiol Lung Cell Mol Physiol. 2018. PMID: 28935640 Free PMC article. - Nitric oxide suppresses LPS-induced inflammation in a mouse asthma model by attenuating the interaction of IKK and Hsp90.
Lee MY, Sun KH, Chiang CP, Huang CF, Sun GH, Tsou YC, Liu HY, Tang SJ. Lee MY, et al. Exp Biol Med (Maywood). 2015 Apr;240(4):498-507. doi: 10.1177/1535370214554880. Epub 2014 Dec 16. Exp Biol Med (Maywood). 2015. PMID: 25519430 Free PMC article. - Are mast cells instrumental for fibrotic diseases?
Overed-Sayer C, Rapley L, Mustelin T, Clarke DL. Overed-Sayer C, et al. Front Pharmacol. 2014 Jan 21;4:174. doi: 10.3389/fphar.2013.00174. eCollection 2013. Front Pharmacol. 2014. PMID: 24478701 Free PMC article. Review. - Eosinophil chemotactic chemokine profilings of the brain from permissive and non-permissive hosts infected with Angiostrongylus cantonenis.
Li S, Yang F, Ji P, Zeng X, Wu X, Wei J, Ouyang L, Liang J, Zheng H, Wu Z, Lv Z. Li S, et al. Parasitol Res. 2014 Feb;113(2):517-25. doi: 10.1007/s00436-013-3683-x. Parasitol Res. 2014. PMID: 24233410 - Hematopoietic G-protein-coupled receptor kinase 2 deficiency decreases atherosclerotic lesion formation in LDL receptor-knockout mice.
Otten JJ, de Jager SC, Kavelaars A, Seijkens T, Bot I, Wijnands E, Beckers L, Westra MM, Bot M, Busch M, Bermudez B, van Berkel TJ, Heijnen CJ, Biessen EA. Otten JJ, et al. FASEB J. 2013 Jan;27(1):265-76. doi: 10.1096/fj.12-205351. Epub 2012 Oct 9. FASEB J. 2013. PMID: 23047899 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical